Konsensustreffen Mammadiagnostik 2021: Online-Austausch unter Pandemie-Bedingungen

Die weltweite COVID-19-Pandemie stellt auch Konsensusveranstaltungen vor neue Herausforderungen. Das 2-jährlich in Frankfurt am Main stattfindende Konsensustreffen von Kursleitern in der Mammadiagnostik konnte dieses Mal nur dank der exzellenten Unterstützung einer bereits seit Jahren etablierten Online-Fortbildungsreihe ermöglicht werden.

Publication History

Article published online:
10 June 2022

• Literatur

• 1 Müller-Schimpfle M. Konsensustreffen der Kursleiter in der Mammadiagnostik am 5.5.2007 in Frankfurt am Main – Thema: Mikrokalk. Fortschr Röntgenstr 2008; 180: 66-68
• 2 Müller-Schimpfle MP, Heindel W, Kettritz U. et al. Konsensustreffen der Kursleiter in der Mammadiagnostik am 9.5.2009 in Frankfurt am Main – Thema Herdbefunde. Fortschr Röntgenstr 2010; 182: 1-5
• 3 Müller-Schimpfle MP, Heindel W, Kettritz U. et al. Konsensustreffen der Kursleiter in der Mammadiagnostik am 9.5.2009 in Frankfurt am Main – Thema Herdbefunde. Fortschr Röntgenstr 2012; 184: 919-924
• 4 Müller-Schimpfle MP, Heindel W, Kettritz U. für die AG Mammadiagnostik der DRG. et al. Konsensustreffen der Kursleiter in der Mammadiagnostik am 04.05.2013 in Frankfurt am Main – Standards in Technik und Befundung. Fortschr Röntgenstr 2014; 186: 410-416
• 5 Müller-Schimpfle M, Bick U, Hahn M. et al. Senologie – Zeitschrift für Mammadiagnostik und -therapie. 2017; 14: 78-81
• 6 Müller-Schimpfle M, Bader W, Baltzer P. et al. Consensus Meeting of Breast Imaging: BI-RADS and Beyond. Breast Care 2019; 14: 308-314
• 7 Alabousi M, Wadera A, Kashif Al-Ghita M. et al. Performance of digital breast tomosynthesis, synthetic mammography and digital mammography in breast cancer screening: a systematic review and meta-analysis. J Natl Cancer Inst 2021; 113: 680-690
• 8 Johnson MM. Full-Field Digital Mammography and Digital Breast Tomosynthesis. Radiol Technol 2017; 88: 299M-319M
• 9 Sardanelli F, Aase HS, Álvarez M. et al. Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies fromAustria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey. Eur Radiol 2017; 27: 2737-2743
• 10 Müller-Schimpfle M, Graf O, Madjar H. et al. Diskussionspapier – BI-RADS die 5. – eine Kurzmitteilung aus deutsch-/österreichischer Sicht. Röfo 2016; 188: 346-352
• 11 Lee JM, Arao RF, Sprague BL. et al. Performance of Screening Ultrasonography as an Adjunct to Screening Mammography in Women Across the Spectrum of Breast Cancer Risk. JAMA Intern Med 2019; 179: 658-667
• 12 Yang L, Wang S, Zhang L. et al. Performance of ultrasonography screening for breast cancer: a systematic review and meta-analysis. BMC Cancer 2020; 20: 499
• 13 Harada-Shoji N, Suzuki A, Ishida T. et al. Evaluation of Adjunctive Ultrasonography for Breast Cancer Detection Among Women Aged 40–49 Years With Varying Breast Density Undergoing Screening Mammography: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open 2021; 04: e2121505
• 14 Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF). S3-Leitlinie Früherkennung, Diagnose, Therapie und Nachsorge des Mammakarzinoms, Version 4.0, 2017 AWMF Registernummer: 032–045OL. Accessed January 01, 2018 at: http://www.leitlinienprogramm-onkologie.de/leitlinien/mammakarzinom/
• 15 An P, Zhong S, Zhang R. et al. A Cross-Sectional Observational Study to Compare the Role of Ultrasound with Mammography in Women Identified at High Risk for Breast Cancer in a Population in China. Med Sci Monit 2020; 26: e919777
• 16 Berg WA, Bandos AI, Mendelson EB. et al. Ultrasound as the Primary Screening Test for Breast Cancer: Analysis From ACRIN 6666. J Natl Cancer Inst 2015; 108: djv367
• 17 Weigel S, Heindel W, Heidrich J. et al. Digital mammography screening: sensitivity of the programme dependent on breast density. Eur Radiol 2017; 27: 2744-2751
• 18 Tagliafico AS, Mariscotti G, Valdora F. et al. A prospective comparative trial of adjunct screening with tomosynthesis or ultrasound in women with mammography-negative dense breasts (ASTOUND-2). Eur J Cancer 2018; 104: 39-46
• 19 Guergan S, Hoopmann U, Roehm C. et al. Evaluation of sonographic detectability of different markers within an in vitro simulation model of the axilla. Arch Gynecol Obstet 2021; 304: 839-848
• 20 Melnikow J, Fenton JJ, Whitlock EP. et al. Supplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S. Preventive Service Task Force. Ann Intern Med 2016; 164: 268-278
• 21 OʼFlynn EA, Ledger AE, deSouza NM. Alternative screening for dense breasts: MRI. AJR Am J Roentgenol 2015; 204: W141-149
• 22 Li J, Jia Z, Zhang M. et al. Cost-Effectiveness Analysis of Imaging Modalities for Breast Cancer Surveillance Among BRCA1/2 Mutation Carriers: A Systematic Review. Front Oncol 2022; 11: 763161
• 23 Accessed April 08, 2022 at: https://healthcare-quality.jrc.ec.europa.eu/european-breast-cancer-guidelines/dense-breast/MRI
• 24 Bakker MF, de Lange SV, Pijnappel RM. et al. DENSE Trial Study Group. Supplemental MRI Screening for Women with Extremely Dense Breast Tissue. N Engl J Med 2019; 381: 2091-2102
• 25 Mann RM, Athanasiou A, Baltzer PAT. et al. Breast cancer screening in women with extremely dense breasts recommendations of the European Society of Breast Imaging (EUSOBI). Eur Radiol 2022;
• 26 Bick U, Endel C, Krug B. et al. High-risk breast cancer surveillance with MRI: 10-year experience from the German Consortium for Hereditary Breast and Ovarian Cancer. Breast Cancer Res Treat 2019; 175: 217-228
• 27 Castelo M, Brown Z, Schellenberg AE. et al. Abnormal screens among nonmutation carriers in the High Risk Ontario Breast Screening Program. Breast J 2021; 27: 423-431